Home » Topics » Regulatory

Regulatory
RSS

FDA approves new labeling for Hyalgan

Jan. 28, 2000

New growth hormone option increases patient convenience

Jan. 25, 2000

Genotropin delivery device now available for long-term replacement therapy in GHD

Jan. 24, 2000

FDA approves two-dose regimen of Merck & Co.'s Recombivax HB for adolescent use

Jan. 21, 2000

KeraVision commences clinical trials for use of Intacs as treatment of keratoconus

Jan. 19, 2000

Clomethiazole: use in spinal cord injury

Jan. 18, 2000

European Commission approves new indication for AstraZeneca antiasthmatic

Jan. 17, 2000

FDA accepts NDA for new Rapamune formulation

Jan. 14, 2000

Once-daily antidiabetic drug from Andrx steadily advances towards market launch

Jan. 11, 2000

New combination therapy for depression with reduced side effects

Jan. 11, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Flow Neuro wins FDA nod for at-home device for depression
BioWorld MedTech
Flow Neuroscience AB received U.S. FDA 510(k) approval for its Flow at-home brain-stimulation device to treat major depressive disorder. The wearable headset uses...